TB Research

Case report of a near-fatal case of Mycobacterium massiliense sepsis after de-clotting of an arteriovenous fistula

Haroon Nawaz, Ayesha Choudhry, William Morse

The Egyptian Journal of Internal Medicine · 2021-12

Abstract

Abstract Background Mycobacterium massiliense is a rapidly growing a non-tuberculous mycobacterium that has been validated as a separate species from the Mycobacterium abscessus group. Only few antibiotics have demonstrated germicidal activity against Mycobacterium massiliense , and some of those include amikacin, clarithromycin, and cefoxitin. Case presentation We present the first reported case of near-fatal septic shock caused by disseminated Mycobacterium massiliense after de-clotting of an infected arteriovenous fistula, in a patient with end-stage renal disease with concomitant human immunodeficiency virus infection. Early recognition of the culprit organism and treatment with a combination therapy of clarithromycin and amikacin led to rapid improvement. Conclusion This unique case can highlight the importance of taking into consideration Mycobacterium massiliense infection as a cause of arteriovenous fistula thrombosis and highlights the risk of disseminated infection leading to life threatening sepsis upon de-clotting of the fistula.

MeSH terms

  • Medicine
  • Clarithromycin
  • Amikacin
  • Arteriovenous fistula
  • Mycobacterium chelonae
  • Microbiology
  • Mycobacterium abscessus
  • Mycobacterium
  • Antibiotics